IL37 and hepatocellular carcinoma: Moreover, studies have determined that IL-37 can suppress tumor progression, migration, invasion and metastasis in multiple cancer types, including fibrosarcoma (134), hepatocellular carcinoma (HCC)(135), cervical cancer (136), lung cancer (137) and colon cancer (138).